Abnormal expression of OPN and CISD2 has been shown to play a key role in the progression of PC [7, 8], while PAM4, S100A6, and SPARC have been identified as biomarkers of PC [9–11]. This evidence concerns the gene SPARC and pachyonychia congenita.